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The cell nucleus contains two closely related structures,
Cajal bodies (CBs) and gems. CBs are the first site
of accumulation of newly assembled splicing snRNPs
(small nuclear ribonucleoproteins) following their import
into the nucleus, before they form their steady-state
localization in nuclear splicing speckles. Gems are the
nuclear site of accumulation of survival motor neurons
(SMNs), an insufficiency of which leads to the inherited
neurodegenerative condition, spinal muscular atrophy
(SMA). SMN is required in the cytoplasm for the addition
of core, Sm, proteins to new snRNPs and is believed to
accompany snRNPs to the CB. In most cell lines, gems are
indistinguishable from CBs, although the structures are
often separate in vivo. The relationship between CBs and
gems is not fully understood, but there is evidence that
symmetrical dimethylation of arginine residues in the CB
protein coilin brings them together in HeLa cells. During
neuronal differentiation of the human neuroblastoma cell
line SH-SY5Y, CBs and gems increase their colocalization,
mimicking changes seen during foetal development. This
does not result from alterations in the methylation of
coilin, but from increased levels of SMN. Expression
of exogenous SMN results in an increased efficiency
of snRNP transport to nuclear speckles. This suggests
different mechanisms are present in different cell types
and in vivo that may be significant for the tissue-specific
pathology of SMA.
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The inherited neurodegenerative disorder, spinal muscular
atrophy (SMA) results from expression of too little of
the protein survival motor neurons (SMNs) (1). SMA is
characterized by the degeneration of motor neurons in
the spinal cord, resulting in progressive atrophy of skeletal
muscles. SMA occurs with a frequency of 1 in 10 000 live
births, making it the leading genetic cause of infant death.
There is currently no effective treatment. Although the
genetic cause of the disease is known, the mechanism
by which lowered SMN expression leads to selective loss
of motor neurons is not understood. SMN is found in
the cytoplasm of the cell and in small nuclear bodies
called gems [gemini of Cajal bodies (CBs)] (2). Gems are
closely related to CBs and in many cultured cell lines
the two are indistinguishable. In vivo CBs and gems are
often seen as separate structures in foetal tissues, with
the percentage of nuclear bodies containing both SMN
and coilin increasing with foetal age. This suggests that
their colocalization may be developmentally regulated (3).
Interestingly, the greatest degree of colocalization of
CBs and gems, 50%, is seen in motor neurons of
the spinal cord. Cytoplasmic SMN is required for the
correct assembly of essential pre-mRNA splicing factors
called small nuclear ribonucleoproteins (snRNPs). The core
snRNPs, Sm proteins, are assembled in a ring around the
core snRNA (4,5) by a process involving SMN together
with a number of associated proteins [reviewed in (6)].
CBs are the first site of accumulation of newly imported
snRNPs in the nucleus (7) and they have been implicated
in nuclear stages of snRNP biogenesis (8,9). There is
also increasing evidence that they have role in snRNP
recycling (10–12). Thus, gems and CBs are linked both by
their close physical association and by their involvement
in the same molecular pathway.
Because pre-mRNA splicing factors are required in all
cells, their biogenesis can be regarded as a housekeeping
function. The total absence of SMN is lethal to cells (13).
The highly selective pathology seen in SMA is, there-
fore, difficult to explain. There is evidence to suggest
that SMN may have additional functions in neural cells,
as it is found in granules actively transported in neuronal
processes (14). In addition, defects in axon outgrowth
have been reported in zebra fish and mouse models of
SMA (15–17). However, the defects seen in zebra fish
can be rescued by the injection of exogenous snRNPs (16).
While motor neurons are typically regarded as the affected
cell type in SMA, there is also some evidence that differ-
entiated muscle cells may be damaged by lowered levels
of SMN (18,19), while defects in motoneuron junctions
have been demonstrated to be the earliest pathology in
mouse models of SMN (20,21). Recently, it has been sug-
gested that lowered levels of SMN selectively affect the
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biogenesis of certain snRNPs, particularly those involved
in the minor spliceosome (22,23) and lead to widespread
splicing defects (23). It is clear, therefore, that a fuller
understanding of the mechanisms controlling snRNP bio-
genesis is required. In particular, any differences seen
between differentiated and undifferentiated cells and,
specifically, neural and non-neural cell types may shed
light on the molecular pathology of SMA.
There is evidence that protein methylation is required
for the correct localization and function of certain nuclear
proteins (24,25). In particular, the CB signature protein,
coilin, has been demonstrated to contain symmetrically
dimethylated arginine (sDMA) residues. In HeLa cells,
the correct methylation of coilin is required for its bind-
ing to SMN and for the colocalization of gems and CBs.
Strains of HeLa showing separation of CBs and gems
were demonstrated to undermethylate green fluorescent
protein (GFP)-coilin (25). In this study, we have investi-
gated the relationship between CBs and gems and the
methylation of endogenous coilin in the human neuroblas-
toma cell line SH-SY5Y as it undergoes differentiation and
neurite outgrowth. The colocalization between CBs and
gems increases during differentiation, mimicking changes
seen during development in vivo. However, despite the
presence of sDMAs in coilin in SH-SY5Y cells, we find no
evidence for changes in the methylation of coilin during
differentiation. In contrast to previous studies in HeLa cells
and fibroblasts (26,27), we find that the level of expression
of SMN is a key regulator of the relationship between CBs
and gems in differentiating neuroblastoma cells. As the
prevailing view is that the role of the CB/gem complex is to
increase the efficiency of snRNPmaturation (11,28), these
findings have important implications for the understanding
of the tissue-specific nature of SMA.
Results
Differentiation of SH-SY5Y cells is associated with
increased colocalization of Cajal bodies and gems
In many commonly studied cell lines, CBs and gems
are indistinguishable from each other. CBs are identified
by the presence of coilin and are implicated in
nuclear stages of splicing snRNP maturation, while
gems contain the SMN protein known to be important
for earlier, cytoplasmic, stages of snRNP biogenesis.
In vivo, however, CBs and gems are separate in
foetal tissues and colocalized in the equivalent adult
tissues (29). The neuroblastoma cell line, SH-SY5Y, can
be induced to undergo differentiation in vitro by addition
of retinoic acid (RA) (Figure 1C,D) or by the sequential
use of RA followed by brain-derived neurotrophic factor
(BDNF) (Figure 1E,F) (30,31). Both treatments result in
the extension of neurites from the cells (Figure 1D,F,
arrows). However, some cells within the population
remain undifferentiated in cultures treated with RA alone
(Figure 1C,D, arrowheads). These cells are not seen in
cultures subsequently treated with BDNF, in which all
Figure 1: SH-SY5Y cells can be differentiated in culture.
Phase-contrast images of SH-SY5Y cells undifferentiated (A and
B) and following differentiation for 10 days with retinoic acid (C
and D) or 4 days with retinoic acid followed by 6 days with BDNF
(E and F). Using either differentiation protocol, the cells extend
long neural processes (arrows). Using retinoic acid alone, a few
cells do not adopt a neural morphology (arrowheads in C and D).
Bar = 100 μm (A, C and E) or 30 μm (B, D and F).
cells develop a neural appearance providing a reproducible
method to produce uniformly differentiated cells. To
investigate the relationship between CBs and gems in
undifferentiated and RA+BDNF-differentiated SH-SY5Y
cells, cells were fixed with 3.7% paraformaldehyde
and nuclear bodies detected using antibodies to the
CB marker, coilin, and to SMN. In undifferentiated SH-
SY5Y cells, CBs and gems are present predominantly
as separate structures (Figure 2Ai), with just 10%
of nuclear bodies containing both SMN and coilin
(Figure 2B). Following differentiation with RA and BDNF,
the percentage of nuclear bodies containing both SMN
and coilin increases to around 25% (Figure 2Aii,B). There
is a corresponding statistically significant increase in the
number of colocalized CBs (coilin) and gems (SMN) per
cell (Figure 2C). SH-SY5Y cells thus represent a suitable
model of neural differentiation for examining molecular
mechanisms regulating the relationship between CBs and
gems. Because the RA+BDNF differentiation protocol
involves several days’ growth in serum-free medium,
SH-SY5Y cells were grown for 10 days in serum-free
medium to ensure that the changes seen were not
because of growth arrest resulting from serum starvation.
Serum-starved cells did not show any increase in the
colocalization of nuclear bodies (data not shown).
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Figure 2: Cajal bodies and gems
increase their colocalization on
differentiation. A) SH-SY5Y cells
grown without (i) or with (ii) RA
followed by BDNF. Nuclear gems
containing SMN alone (green,
arrow in i) and CBs containing
coilin alone (red, arrowhead in i)
are seen frequently in undifferen-
tiated cells. In differentiated cells,
the proportion of nuclear bodies
containing both SMN and coilin
is increased (arrows in ii). Bar =
10 μm. B) Graph showing the per-
centage of total nuclear bodies that
contain both SMN and coilin before
and after differentiation with RA
and BDNF (total n = 335 cells,
three independent experiments).
C) Graph showing the increase
in number of colocalized bodies
per cell. The change is statistically
significant using an unpaired, two-
tailed t-test (p < 0.001).
Global downregulation of methylation in SH-SY5Y
cells leads to a separation of coilin and SMN bodies
and a loss of coilin-positive bodies in general
The CB marker protein, coilin, has been shown to be
subject to symmetrical dimethylation of arginine (24,25)
with this modification (sDMA) increasing the affinity
of coilin for binding both to SMN and to the Sm
protein components of splicing snRNPs in in vitro
binding assays (32). It has thus been proposed that the
presence of methylated coilin results in the formation
of nuclear bodies containing both coilin and SMN, with
hypomethylated coilin being present in cells with separate
CBs and gems. The inhibitor of protein methylation,
5′-deoxy-5′-methylthioadenosine (MTA), has been shown
to result in the appearance of gems, containing only
SMN, in HeLa cells that normally contain colocalized
CBs and gems (24). A different methylation inhibitor,
adenosine dialdehyde (AdOx), was shown to decrease
methylation of coilin, but did not result in separation of
CBs and gems (25). To determine if protein methylation
is important for the association between CBs and
gems in SH-SY5Y cells, we treated undifferentiated
and RA+BDNF-treated cells with AdOx and MTA. In
contrast to results from HeLa cells, both inhibitors
resulted in a decrease in colocalization of coilin and
SMN (Figure 3A–C). This was accompanied by a general
decrease in the number of nuclear CBs present
(Figure 3D), suggesting that the decreased association
between CBs and gems results from a loss of CBs, rather
than a separation of colocalized bodies.
RNAi-mediated reduction of PRMT5 affects HeLa cells
and SH-SY5Y cells differently
The metabolic inhibitors Adox and MTA cause a general
inhibition of protein methylation. To focus further on the
role of methylation of coilin in maintaining CB integrity, we
employed siRNA to reduce the levels of the methylase
protein methyl arginine transferase 5 (PRMT5), which is
responsible for addition of sDMA modifications to coilin
and the Sm proteins (24,33). Four duplexes were used
individually and as a mix. Hela cells electroporated with
duplexes to reduce the levels of PRMT5 (Figure 4A,B, and
other data not shown) showed a striking reorganization
of coilin into large irregular structures (arrows). These
structures were seen in 46% of cells electroporated with
a mix of four duplexes (n = 126), 17% with duplex A
(n = 233) and 26%with duplex B (n = 156). This compares
with less than 1% in control cells (n = 468). Interestingly,
the subcellular distribution of SMN was also disrupted in
these cells, with colocalization of SMN and coilin seen
in the aberrant irregular structures. This suggests that
direct molecular interaction between methylated coilin
and SMN is not the major cause of colocalization of CBs
and gems. Electroporation of SH-SY5Y cells with siRNA
duplexes to reduce PRMT5 levels did not result in the
presence of abnormal nuclear bodies or major changes in
the distribution of coilin and SMN between nuclear bodies
(Figure 4B,C, and other data not shown). This adds further
weight to the suggestion that nuclear bodies are regulated
differently in different cell types.
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Figure 3: Inhibition of protein methylation causes separation of CB and gems. A) Top panel: antibodies to SMN (magenta) and
coilin (green) show very little colocalization in undifferentiated or BDNF-differentiated cells treated for 24 h with AdOx or MTA. Very few
coilin-containing CBs are seen (arrows). Bottom panel: DAPI (4′-6-Diamidino-2-phenylindole) counterstaining of nuclei. B) The percentage
of nuclear bodies containing both SMN and coilin is decreased in cells treated with AdOx or MTA (total n = 657). C) The number of
bodies per cell containing both SMN and coilin is decreased in cells treated with AdOx or MTA. D) The average number of coilin-positive
foci per cell decreases on inhibition of methylation. Changes between untreated and treated populations are significant using one-way
ANOVA with Bonferroni multiple comparison post-test.
Coilin shows equivalent methylation and affinity for
binding SMN in undifferentiated and differentiated
cells
To investigate directly the methylation of endogenous
coilin in undifferentiated and differentiated SH-SY5Y cells,
we carried out immunoprecipitation of sDMA-containing
proteins using the antibodies Y12 and SYM10, both
of which recognize sDMA motifs (24,34) (Figure 5). In
both undifferentiated and RA+BDNF-differentiated SH-
SY5Y cells, coilin is immunoprecipitated with both
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Figure 4: Reduction of PRMT5by RNAi results
in abnormal nuclear foci containing SMN and
coilin in HeLa cells, but not in SH-SY5Y cells.
A) HeLa cells electroporated with PRMT5 siRNA
duplexes for 48 h labelled with antibodies to
SMN and coilin and counterstained with DAPI.
Both antigens are found in abnormal nuclear foci
(arrows and insets), whether the duplexes are
used as a mix (top row) or separately. Bar =
10 μm. B) Immunoblots to confirm the efficiency
of depletion of PRMT5 from HeLa and SH-SY5Y
cells. Graphs represent pooled data from three
experiments, normalized to tubulin signal and
plotted as a proportion of the negative control.
C) SH-SY5Y cells with lowered PRMT5 show no
significant changes in the distribution of coilin
and SMN in nuclear bodies (one-way ANOVA with
Bonferroni multiple comparison post-test, total
n = 632, p>0.05 for all relevant comparisons).
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Figure 5: Anti-sDMA antibodies immunoprecipitate coilin,
SMN and Sm proteins from undifferentiated and differen-
tiated SH-SY5Y cells. Equal amounts of whole cell lysates
from undifferentiated or BDNF-differentiated SHSY-5Y cells were
used for immunoprecipitation using anti-coilin antibodies and
the anti-sDMA antibodies Y12 and SYM10. Duplicate blots of
immunoprecipitated material were probed with anti-coilin (top),
anti-SMN (middle) and Y12 anti-sDMA (bottom). Endogenous
coilin was immunoprecipitated by anti-coilin, Y12 and SYM10
antibodies. SMN was immunoprecipitated by Y12 and SYM10
antibodies, with a very small amount also immunoprecipitated by
anti-coilin. SmB/B′ was immunoprecipitated by Y12 and SYM10
but not by anti-coilin. The symbol ’*’ denotes detection of anti-
bodies used for immunoprecipitation.
antibodies, demonstrating that the protein is methylated
in differentiated and undifferentiated cells. The Y12
antibody appears to precipitate coilin slightly more
efficiently in differentiated cells. However, this is not
seen using the SYM10 antibody, which was raised
specifically to recognize sDMA. Both Y12 and SYM10 also
efficiently immunoprecipitate the Sm protein components
of snRNPs, which are known to contain sDMA motifs.
SMN is seen in the fractions immunoprecipitated with
SYM10 and Y12. This is likely to be as a result of
interaction between SMN and Sm proteins as SMN
does not have an arginine motif predicted to be
dimethylated (35). The ability of anti-sDMA antibodies to
coimmunoprecipitate SMN has previously been observed
in some, but not all, HeLa cell lines (35). Interestingly,
immunoprecipitation of endogenous coilin (Figure 5A)
does not result in the coimmunoprecipitaiton of Sm
proteins in undifferentiated or differentiated cells. This
suggests that only minor amounts of these proteins,
if any, interact under these conditions. Likewise, the
amount of SMN coimmunoprecipitatedwith coilin is barely
detectable and is not increased in differentiated cells.
Transient overexpression of SmB or coilin does not
increase the colocalization of CBs and gems in
neuroblastoma cells
Previous studies in primary human fibroblasts demon-
strated that expression of exogenous Sm protein was
sufficient to induce the transient formation of CBs con-
taining coilin, SMN and snRNPs (36). On-going snRNP
biogenesis has recently been demonstrated to be essen-
tial for CB integrity (37). However, expression of yellow
fluorescent protein (YFP)-tagged SmB in SH-SY5Y cells
does not result in increased colocalization between the
two nuclear bodies (Figure 6A). Cells expressing YFP-SmB
contain both SMN and coilin in only 7% of total nuclear
bodies (n = 67), which is comparable to untransfected
cells (Figure 2).
The CB protein, coilin, has also been implicated in
enabling the accumulation of SMN and snRNPs in
CBs. Nuclei of cells from a coilin knockout mouse
contain residual CBs that do not accumulate SMN or
snRNPs (38), with a direct interaction betweenmethylated
coilin and SMN the likely molecular mechanism for
the recruitment of SMN/snRNP complexes to CBs (25).
Transient expression of YFP-coilin was, however, not
well tolerated in SH-SY5Y cells (Figure 6B), with only
a minor proportion of transfected cells showing YFP-
coilin in CBs (arrows) while most cells displayed diffuse
nucleoplasmic YFP-coilin, or accumulations of the tagged
protein in nucleoli (arrowheads). To ensure that this
aberrant localization was not caused by an inability of the
cells to methylate YFP-coilin, anti-GFP antibodies were
used to immunoprecipitate YFP-coilin from transfected
SH-SY5Y cells and from a HeLa cell line constitutively
expressing YFP-coilin in which wild-type localization is
seen (27). The YFP-coilin immunoprecipiated from both
cell lines was recognized by the anti-sDMA antibody,
Y12 (Figure 6C), showing that YFP-coilin is methylated in
SH-SY5Y cells as well as in HeLa cells.
1590 Traffic 2009; 10: 1585–1598
SMN Regulates Nuclear Architecture
Figure 6: Over-expression of SmB or coilin does not increase the colocalization of CBs and gems. A) Expression of YFP-SmB in
SH-SY5Y cells does not cause CBs and gems to colocalize. SH-SY5Y cells were transfected with a plasmid to express YFP-SmB (green
in left hand panel). Detection of SMN (magenta) and coilin (green) in these cells reveals separate CBs (arrows) and gems (arrowheads).
Bar = 10 μm. B) YFP-coilin shows aberrant localization in SH-SY5Y cells. Cells transfected with a plasmid to express YFP-coilin (centre
panel and green in right hand panel) show diffuse nucleoplasmic signal for YFP-coilin in most cells, with discrete CBs (arrows) seen in
only a few cells. Accumulation of YFP-coilin in the nucleolus is also commonly seen (arrowheads). Detection of SMN in these cells (left
hand panel and red in right hand panel) shows no obvious disturbance of SMN distribution. Bar = 10 μm. C) YFP-coilin is methylated
in HeLa and SH-SY5Y cells. YFP-coilin was immunoprecipitated from whole cell lysates using anti-GFP antibodies covalently bound
to protein G–sepharose, separated by SDS–PAGE and blotted to nitrocellulose membrane. Anti-GFP (top panels) and Y12 anti-sDMA
(bottom panels) were used to probe duplicate blots. Both antibodies detected a band representing YFP-coilin in both cell lines, confirming
that YFP-coilin contains the symmetrical dimethylarginine motif in SH-SY5Y as well as in HeLa cells.
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The level of SMN, but not that of coilin or Sm
proteins, increases on differentiation
To investigate the potential changes in expression
of endogenous nuclear body proteins associated with
differentiation of SH-SY5Y cells, whole cell lysates
of undifferentiated and BDNF-differentiated cells were
separated on polyacrylamide gels alongside HeLa cell
lysates and transferred to nitrocellulose membranes.
Immunological detection of endogenous coilin, Sm
proteins and SMN revealed a marked increase in SMN
on differentiation (Figure 7). No increase or decrease was
seen in the levels of coilin or Sm proteins.
Overexpression of SMN is sufficient to cause
complete colocalization of CBs and gems in SH-SY5Y
cells
Overexpression of SMN in HeLa cells has previously
been demonstrated to result in cytoplasmic foci (26,27)
and numerous small nuclear bodies. To investigate the
effect of expressing excess SMN in undifferentiated SH-
SY5Y cells, we established a number of cell lines stably
expressing GFP-SMN (Figure 8A). In all of the cell lines
examined, GFP-SMN was found in the cytoplasm and in a
small number of nuclear bodies. These bodies resembled
canonical CBs by size and number andwere demonstrated
to contain coilin. No nuclear bodies containing coilin alone
or containing SMN alone (gems) were detected in these
cell lines, suggesting that the amount of SMN present
is the key determinant of nuclear body architecture in
these cells. Analysis of the level of expression of GFP-
SMN in these cell lines by western blot (Figure 8B)
demonstrates an increase in total SMN levels in these lines
of between 75 and 95%. To confirm that this effect was
specific to the expression of exogenous SMN, we also
established a number of cell lines expressing GFP-tagged
coilin (Figure 8C). In agreement with results obtained
from transient expression of YFP-coilin (Figure 6B), excess
coilin is not well tolerated by SH-SY5Y cells, showing
mostly diffuse localization within the nucleus. One cell
line (GFP-coilin-SHY5) did show GFP-coilin-positive bodies
in approximately 30% of nuclei. In this line, some of the
coilin-positive bodies colocalize with endogenous SMN,
but others do not, as is seen in the parental cell line
(Figure 8C, inset). SMN localization is disrupted in these
cell lines, with SMN-positive gems almost completely
absent. This further emphasizes the importance of the
balance between coilin and SMN levels for the integrity of
nuclear CBs and gems.
SMN depletion leads to a complete loss of Cajal
bodies from SH-SY5Y cells
Depletion of SMN from HeLa cells using siRNA has
been reported to disrupt CBs (28,33,39), resulting in small
nuclear foci containing coilin and some accumulation
of coilin in nucleoli. As CBs and gems represent the
same structure in HeLa cells but are clearly separate in
SH-SY5Y cells, we wanted to determine whether the
reduced physical association between the two structures
in SH-SY5Y cells reflects a reduced functional association.
Cells were microinjected with siRNA duplexes to target
SMN expression. The injected material was labelled with
Texas Red dextran to allow precise identification of the
experimental cells. In HeLa cells, we observed a general
′
Figure 7: SMN levels increase during differentiation of
SH-SY5Y cells. Equal amounts of whole cell lysates from HeLa
cells, undifferentiated SH-SY5Y cells and BDNF-differentiated
SH-SY5Y cells were separated by SDS–PAGE and blotted to
nitrocellulose membrane. The amount of coilin was equal in all
three samples. SmB/B′ was present in slightly lower amounts in
HeLa cells than in SH-SY5Y cells and unaffected by differentiation
of the cells. The level of SMN showed a marked increase (60%,
normalized to β-actin levels) following differentiation of SH-SY5Y
cells. β-actin is included as a loading control.
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increase in diffuse nucleoplasmic coilin, together with
a decrease in size and number of CBs (Figure 9A).
The distribution of the SR splicing factor, SC-35, was
not altered by SMN reduction, confirming that the
rearrangements seen are specific to nuclear bodies and
do not reflect a general disruption of nuclear architecture.
In SH-SY5Y cells, either before or after differentiation,
reduction of SMN led to a total loss of accumulation of
coilin in CBs (Figure 9B), with only diffuse nucleoplasmic
coilin observed. Thus, despite a less obvious relationship
between CBs and gems in SH-SY5Y cells compared with
HeLa cells, the loss of SMN has a greater effect on the
integrity of CBs in these cells. This suggests that the
functional relationship between CBs and gems is of at
least equal importance in SH-SY5Y cells as in HeLa cells.
Increased levels of SMN in SH-SY5Y cells lead to an
increase in the rate of accumulation of Sm proteins in
speckles
The uptake of newly made snRNPs into the nucleus can
be followed using fluorescently tagged Sm proteins (7).
In cell lines studied previously, newly made snRNPs
are at first seen diffusely within the cell, and localize
to CBs prior to their eventual accumulation in nuclear
speckles. Important modifications of the snRNA core
of snRNPs are carried out in the CB (8,9). Interfering
with snRNP biogenesis using metabolic inhibitors (27)
or reduction of SMN levels (39) has been demonstrated
to prevent or reduce the accumulation of newly made
snRNPs in speckles. To determine the effect of increased
levels of SMN on the efficiency of snRNP maturation
in SH-SY5Y cells, the parental cell line and a cell
line constitutively expressing GFPSMN (GFPSMNSHY10)
were transfected with a plasmid to express the core
snRNP protein, SmB taggedwithmCherry (40). Cells were
fixed after 24 and 48 h and the distribution of mCherry-
SmB determined (Figure 10). In SH-SY5Y cells expressing
only endogenous SMN protein, mCherry-SmB is largely
diffuse within the cell after 24 h of expression. In contrast,
cells of line GFPSMNSHY10, which overexpress SMN
by approximately 75%, already show clear accumulation
of mCherry-SmB in nuclear speckles (arrows) and CBs
(arrowheads) after 24 h of expression. After 48 h of
expression, mCherry-SmB shows a clear pattern of
Figure 8: Expression of GFP-SMN leads to complete
colocalization of CBs and gems. A) Three independent SH-
SY5Y cell lines (clones SHY2, SHY8 and SHY10) expressing
GFP-SMN show coilin, detected with anti-coilin antibodies (red
on overlays) and GFP-SMN (green on overlays) fully colocalized
within the nucleus into CB/gem complexes (arrows). A few cells
show cytoplasmic accumulations of GFP-SMN (arrowheads).
These do not contain coilin. Bar = 10 μm. B) Immunoblot of
whole cell lysates from three independent SH-SY5Y cell lines
detected with anti-SMN antibodies. Expression levels of the GFP-
SMN fusion protein are approximately 75% (GFPSMNSHY1),
95% (GFPSMNSHY8) and 82% (GFPSMNSHY10) relative to
endogenous SMN. C) Three independent SH-SY5Y lines (clones
SHY10, SHY12 and SHY5) expressing GFP-coilin (green on
overlays) localized diffusely throughout the nucleoplasm. SMN,
detected with anti-SMN antibodies (red on overlays), also fails
to localize to nuclear bodies in these cells. Line GFP-coilin-SHY5
(bottom row) shows a few small GFP-coilin-positive bodies. Some
of these (arrow) also contain SMN, while some (arrowhead) do
not. Bar = 10 μm.
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Figure 9: Reduction of SMN expres-
sion with RNAi disrupts CBs as
well as gems. A) HeLa cells microin-
jected with siRNA duplexes to reduce
SMN expression (demonstrated by red
signal in TR-dextran panel, far right,
and arrows) lack SMN-containing gems
(left hand panel, green on overlays).
Antibody detection of coilin (top row,
magenta on overlays; bottom row,
green on overlays) shows reduced CBs
and increased diffuse nucleoplasmic
signal. Antibody detection of the non-
snRNP splicing factor, SC-35 (bottom
row, magenta on overlays), reveals
intact nuclear speckles. Bar = 10 μm.
B) Undifferentiated (top row) and
BDNF-differentiated (bottom row) SH-
SY5Y cells microinjected with siRNA
duplexes (red signal in TR-dextran
panel, far right, and arrows) lack SMN-
containing gems. Coilin-containing CBs
(magenta on overlays) are also absent.
Bar = 10 μm.
speckleswithin the nucleus in both cell lines. To determine
whether this increase in the rate of accumulation of
snRNPs in speckles results from an increased efficiency
of SMN-mediated snRNP assembly in the cytoplasm
or from an increased efficiency of stages of snRNP
maturation carried out in the CB, we isolated U snRNAs
from the mCherry-SmB-transfected cells using antibodies
against the characteristic trimethylguanosine (TMG) 5′ cap
structure. Analysis of the bound and unbound fractions
using antibodies to mCherry revealed a similar proportion
of mCherry-SmB assembled onto snRNAs at the 24 h
time-point in both cell lines. This suggests that the
increased efficiency with which cells expressing GFP-
SMN accumulate mCherry-SmB in speckles results from
an increased efficiency of nuclear stages of snRNP
maturation and/or transport, rather than an increase in
the rate of assembly of Sm proteins onto snRNAs by
SMN in the cytoplasm.
Discussion
The sequential use of retinoic acid and BDNF can
reproducibly differentiate SH-SY5Y human neuroblastoma
cells into cells of neural appearance with extensive
neurite outgrowth. A comparison of nuclear bodies
containing SMN (gems) and coilin (CBs) reveals these
two structures to be largely separate in undifferentiated
cells (10% of nuclear bodies contain both antigens).
Following differentiation, the percentage of gems and CBs
colocalized into a CB/gem complex increases reproducibly
to approximately 25%. Detailed comparison of adult
and foetal tissues has demonstrated an increase in
colocalization of coilin and SMN during development in
many tissue types (3,29). This suggests that increased
colocalization of CBs and gems is a feature of cellular
differentiation in vivo. Studies using the rat PC12-derived
cell line U61 (41) also reported an increased recruitment
of SMN to nuclear CBs during neuritogenesis, although
an increased number of gems devoid of coilin was also
seen in differentiated cells. It seems likely, therefore, that
increased presence of SMN in CBs is characteristic of
increased cellular differentiation in vitro and maturation of
tissues in vivo.
Methylation of proteins, particularly the symmetrical
dimethylation of arginine motifs in coilin, has been
implicated in regulation of nuclear body formation (24,25).
Using myc-tagged coilin expressed in HeLa cells, Matera
et al. demonstrated that methylated coilin binds SMNwith
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Figure 10: Increased levels of SMN in SH-SY5Y cells lead to an increase in the rate of accumulation of Sm proteins in speckles.
A) Cells from lines SH-SY5Y and GFPSMNSHY1, expressing GFP-SMN, transiently transfected with a plasmid to express mCherry-SmB.
After 24 h of expression (top row), the mCherry-SmB signal is seen throughout the cell in SH-SY5Y cells, while cells from line
GFPSMNSHY1 show clear accumulation of mCherry-SmB in nuclear speckles (arrows) and CBs (arrowheads). After 48 h of expression
(bottom row), both cell lines show a similar accumulation of mCherry-SmB in nuclear speckles. Bar = 10 μm. B) Immunoisolation of U
snRNPs from cells expressing mCherry-SmB for 24 h using antibodies to the TMG cap of U snRNAs. Similar amounts of mCherry-SmB
are associated with U snRNAs from the two cell lines [compare bound (TMG) to unbound (TMG)].
a higher efficiency than does unmethylated coilin. Certain
strains of HeLa in which CBs and gems fail to colocalize do
not methylate GFP-coilin efficiently. Inhibition of protein
methylation in SH-SY5Y cells using AdOx or MTA results
in a decreased association between CBs and gems in
undifferentiated and in differentiated cells (Figure 3). This
is associated with a general decrease in coilin-positive
bodies. These results are in partial agreement with the
previous results in HeLa cells (24,25), although in HeLa
cells MTA, but not AdOx, caused dissociation of CBs
and gems. This difference suggests that the regulation
of nuclear body morphology may be subtly different in
neural cells compared with other cell types. Reduction
in expression of PRMT5, responsible for the addition of
methyl groups to coilin, results in a severe disruption
of CBs in HeLa cells [this study and (33)], but has a
very little effect on nuclear bodies in SH-SY5Y cells.
Despite the disruption seen in HeLa cells, coilin and
SMN remain closely colocalized. This suggests that the
direct molecular interactions between methylated coilin
and SMNmay not be the key determinant of whether CBs
and gems colocalize. Symmetrical arginine dimethylation
of core snRNP, Sm, proteins is required for their efficient
assembly onto snRNAs during the cytoplasmic stages of
snRNP assembly (42–44), as SMN binds preferentially
to methylated Sm proteins. Downregulation of the
methyltransferases PRMT5 and PRMT7 has been shown
to decrease the efficiency of snRNP assembly (33). As
disruption of CBs has previously been seen following
inhibition of snRNP biogenesis (36,37,45), reduction of
snRNP maturation may contribute to the separation of
gems and CBs in cells treated with global methylase
inhibitors.
The prevailing view is that the purpose of accumulation
of factors into the CB/gem complex is to provide
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increased local concentrations of rate-limiting factors for
assembly and recycling pathways and so to increase their
efficiency (11,46). Cultured primary cells remain viable in
the absence of visible CBs (47), while the coilin knockout
mouse shows somewhat decreased viability depending
on the genetic background (38). These data suggest that
processes normally occurring in CBs can be carried
out elsewhere within the nucleus, but probably less
efficiently. As increasing information becomes available
about the effects of overexpression and reduction of
expression of proteins involved in the CB/gem complex,
it is clear that the balance between these molecular
components is key to the correct formation and, by
inference, function of the complex. Cells from the coilin
knockout mouse contain residual CBs that accumulate
nucleolar markers typical of canonical CBs but do not
recruit SMN or snRNPs. In these cells, SMN is found in
gems, separate from other CB markers (38). Expression
of exogenous coilin in these cells leads to the formation
of normal CB/gem complexes containing coilin, SMN and
Sm proteins. Moderate overexpression of coilin in HeLa
cells or primary cells does not lead to increased number
of CBs (27,48–50), with tagged versions of coilin showing
wild-type localization. However, high levels of expression
of GFP-coilin in HeLa cells can lead to disruption of the
CB/gem complex (51). Disruption of CBs is seen in SH-
SY5Y cells transiently expressing exogenous coilin, with
very few transfected cells showing correct localization
of YFP-coilin (Figure 6). Stable overexpression of GFP-
coilin results in an almost complete loss of CBs and
gems (Figure 8C). Expression of GFP-tagged Sm proteins,
predicted to result in upregulation of the snRNPmaturation
pathway, is sufficient to cause the formation of CBs
containing coilin, SMN and Smproteins in primary cell lines
that normally lack CBs. Furthermore, GFP-Sm expression
causes the colocalization of CBs and gems in strains
of HeLa cell where they are usually separate (36). This
suggests that, in these cells, the CB/gem complex forms
in response to upregulation of snRNP maturation. In SH-
SY5Y cells, however, expression of YFP-SmB has no
effect on nuclear bodies (Figure 4B), raising the possibility
that there is a difference in the regulation of nuclear body
formation between neural SH-SY5Y cells and other cell
types studied to date. If this proves to be the case for
other neural cell types, it may be highly significant for
elucidating the molecular defects responsible for SMA.
The most striking differentiation-associated change in
endogenous nuclear body proteins in neural cells is an
increase in SMN (Figure 7). During differentiation in two
neural cell types, human SH-SY5Y (this study) and rat
U61 (41), SMN increases its level and its accumulation
in CBs. While this does not rule out upregulation of
SMN as a general feature of cellular differentiation, it
does suggest that increased SMN levels are associated
with neural differentiation and the extension of neurites.
Cells unable to sufficiently increase their SMN levels may
differentiate less efficiently and be susceptible to damage
or death. Expression of GFP-SMN in SH-SY5Y cells leads
to complete colocalization of coilin and SMN into CB/gem
complexes (Figure 8). Thus, in these cells, it is not a lack of
coilin, defects in coilin methylation or low levels of snRNP
maturation that lead to the separation of CBs and gems,
but a restrictive level of SMN. The complete absence
of nuclear gems and CBs in SH-SY5Y cells with SMN
expression lowered by RNAi (Figure 9) supports this view.
Expression of additional SMN in SH-SY5Y cells not only
causes the colocalization of coilin and SMN into a CB/gem
complex but also increases the rate of accumulation of
newly imported snRNPs in nuclear speckles (Figure 10).
This observation ties the presence of a CB/gem complex
containing both coilin and SMN to an increased efficiency
of snRNP maturation.
It still remains to be discovered whether defects in snRNP
biogenesis are responsible for the motor neuron-specific
pathology seen in SMA. Disturbance of snRNP maturation
has been demonstrated in a severe mouse model of
SMA (22,23) and in cells with levels of SMN reduced to
5% of wild type (23). Associated tissue-specific defects
in pre-mRNA splicing were seen. Defects in motor axon
outgrowth and path finding have been documented in
zebra fish models of SMN (15,16). However, these were
rescued by purified snRNPs (16), suggesting a direct link
between the function of SMN in snRNP maturation and
the cytoskeletal phenotype in axons and growth cones.
This, again, suggests that SMN is involved in delicately
balanced systems: the reduction of overall levels of SMN
may cause a preferential loss of axon-specific functions
of SMN in order to preserve the essential housekeeping
role of SMN in supplying sufficient snRNPs to the splicing
machinery. More drastic or more prolonged lack of SMN
may lead to disruption of snRNP biogenesis and splicing.
Materials and Methods
Cell culture and differentiation
SH-SY5Y andHeLa cell lineswere routinely cultured in Dulbecco’smodified
Eagles’medium (DMEM, Invitrogen) supplementedwith 10% foetal bovine
serum (Invitrogen). For immunofluorescence assays, cells were grown on
coverslips and transfected (if necessary) using Effectene transfection
reagent (Qiagen) according to the manufacturer’s instructions. For the
preparation of cell lysates, cells were grown in 10 cm diameter dishes.
To obtain differentiated cultures of SH-SY5Y cells, retinoic acid (Sigma)
was added to the medium at a final concentration of 10 nM for 10 days.
Alternatively, retinoic acid was added to the medium for 4 days, after
which the medium was replaced with serum-free medium containing 2
nM BDNF (Sigma). The cells were cultured for a further 6 days. To inhibit
protein methylation, cells were cultured for 24 h with either 750 μM MTA
(Sigma) or 100 μM AdOx (adenosine periodate, Sigma).
Cell fixation, immunostaining and microscopy
HeLa cells grown on glass coverslips were fixed for 5 min at room
temperature with 3.7% paraformaldehyde in PHEM buffer [60 mM PIPES,
25 mM HEPES, 10 mM EGTA, 2 mM MgCl2 (pH 6.9)]. Immunostaining was
carried out as described previously (27). Cells weremounted in Vectashield
medium (Vector labs). Antibodies used were rabbit 204/10 anti-coilin
(a gift from A. I. Lamond) (dilution 1:500), mouse monoclonal antibody
(mAb) MANSMA1 anti-SMN (29) (dilution 1:10), SC-35 (Sigma) (dilution
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1:2000), fluorescein isothiocyanate (FITC)- and tetramethylrhodamine
isothiocyanate
(TRITC)-conjugated goat anti-mouse, Cy5- and TRITC-conjugated goat
anti-rabbit immunoglobulin (IgG) (Jackson ImmunoResearch Laboratories)
(dilution 1:250). Immunostained specimens were examined using a Zeiss
Axiovert 2 (63× objective) and recorded using a Hammamatsu C4742-
80-12AG camera with Volocity software (Improvision) (Figures 1 and 2)
or examined and recorded using a DeltaVision Spectris Deconvolution
microscope (60× or 100× objective) (Figures 4, 6, 8, 9 and 10). In both
cases, optical sections separated by 200 nmwere collected using a binning
of 2 × 2.
Image processing and analysis
Maximum intensity projections of serial sections were generated using
Volocity (Improvision) and colour overlays generated, where appropriate,
using Adobe Photoshop. Counts of number of nuclear bodies were made
using Volocity (Improvision) and statistical analyses performed using Prism
(GraphPad).
siRNA knockdowns
For knockdown of PRMT5 by electroporation, cells were electropo-
rated with SmartPool siRNA duplexes (Dharmacon) using an AMAXA
Nucleofector program G-04, 25 μg siRNA per 2 × 106 cells, with
Ingenio electroporation solution (Mirus) according to the manufac-
turer’s instructions. Sequences used were PRMT5: CAACAGAGAUC-
CUAUGAUU (A), CCAAGUGACCGUAGUCUCA (B), UGGCACAACUUCCG-
GACUU (C), CGAAAUAGCUGACACACUA (D) or a mixture of all four,
SMN: CAGUGGAAAGUUGGGGACA, negative control targeting luciferase:
UAAGGCUAUGAAGAGAUAC, positive control targeting cyclophilin B:
GGAAAGACUGUUCCAAAAA. For knockdown of SMN by microinjection,
cells were microinjected with siRNA duplexes diluted in injection buffer
[100 mM glutamic acid pH 7.2 (with citric acid); 140 mM KOH; 1 mM MgSO4
and 1 mM DTT] containing lysine-fixable Texas Red-labelled dextran (Invit-
rogen) using an Eppendorf Injectman NI 2 mounted on a Zeiss Axiovert 40
microscope.
Plasmid constructs and cell lines
Plasmids to express EGFP-SMN, EGFP-coilin, EYFP-SmB and EYFP-coilin
have been described previously (27,36). The plasmid to express mCherry-
SmB was generated by subcloning the SmB cDNA from pEYFP-SmB
into plasmid pmCherry-C1 (40). Stable cell lines were established using
G418 selection of SH-SY5Y cells following transfection with Effectene
transfection reagent (Qiagen) as described previously (36).
Preparation of cell lysates, immunoblotting and
immunoprecipitation
Lysates were prepared as described previously (27,36), electrophoresed
on a 10% SDS polyacrylamide gel and transferred to nitrocellulose
membranes for immunoblotting. Antibodies used were mAbs Y12 anti-
sDMA (Abcam, 1:500); MANSMA1 anti-SMA (a gift from Professor
G. Morris, 1:500); p∂ anti-coilin (Sigma, 1:1000), anti-α-tubulin (Sigma,
1:2000) and AC-15 anti-β-actin (Sigma, 1:2000); rabbit polyclonals 204/10
anti-coilin (a gift from Professor A. I. Lamond, 1:500) and anti-PRMT5
(Abcam, 1:250). Secondary antibodies were horseradish peroxidase (HRP)-
conjugated anti-mouse or anti-rabbit (Pierce, 1:20 000). Detection was
carried out with ECL Plus Western Blotting Detection System (GE
Healthcare) and imaged using a Fujifilm LAS-3000 imaging system.
Immunoprecipitation using anti-GFP antibodies (Roche) was performed
as described previously (52). Primary antibodies used were mAb anti-
GFP (Roche, 1:1000) and Y12 anti-sDMA (Abcam). To immunoprecipitate
endogenous proteins, 500 μg of pre-cleared whole cell lysate was shaken
overnight at 4◦C with 5 μg of Y12 (Abcam) or SYM10 (Upstate Biotech)
anti-sDMA antibodies or with a mixture of 12 μg p∂ anti-coilin (Sigma)
and 2 μg of anti-coilin (BD Biosciences) (53). Protein G–Sepharose beads
(50 μL per sample) were then added and the samples shaken at 4◦C for
a further 4 h. Following four brief washes with cell lysis buffer, the beads
were resuspended in SDS–PAGE sample buffer for electrophoresis and
subsequent immunodetection. Immunoprecipitation of snRNPs using anti-
trimethylguanosine antibodies (Calbiochem) was carried out as described
previously (36). Antibodies for detection were rat monoclonal to dsRed
(a gift from Professor H. Leonhardt, 1:150) and HRP-conjugated anti-rat
(Pierce, 1:20 000).
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